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Abstract
The type VI secretion system (T6SS) has emerged as an important mediator of interbacterial interactions. A T6SS from
Pseudomonas aeruginosa targets at least three effector proteins, type VI secretion exported 1–3 (Tse1–3), to recipient Gram-
negative cells. The Tse2 protein is a cytoplasmic effector that acts as a potent inhibitor of target cell proliferation, thus
providing a pronounced fitness advantage for P. aeruginosa donor cells. P. aeruginosa utilizes a dedicated immunity protein,
type VI secretion immunity 2 (Tsi2), to protect against endogenous and intercellularly-transferred Tse2. Here we show that
Tse2 delivered by the T6SS efficiently induces quiescence, not death, within recipient cells. We demonstrate that despite
direct interaction of Tsi2 and Tse2 in the cytoplasm, Tsi2 is dispensable for targeting the toxin to the secretory apparatus. To
gain insights into the molecular basis of Tse2 immunity, we solved the 1.00 A ˚ X-ray crystal structure of Tsi2. The structure
shows that Tsi2 assembles as a dimer that does not resemble previously characterized immunity or antitoxin proteins. A
genetic screen for Tsi2 mutants deficient in Tse2 interaction revealed an acidic patch distal to the Tsi2 homodimer interface
that mediates toxin interaction and immunity. Consistent with this finding, we observed that destabilization of the Tsi2
dimer does not impact Tse2 interaction. The molecular insights into Tsi2 structure and function garnered from this study
shed light on the mechanisms of T6 effector secretion, and indicate that the Tse2–Tsi2 effector–immunity pair has features
distinguishing it from previously characterized toxin–immunity and toxin–antitoxin systems.
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Introduction
The type VI secretion system (T6SS) is a multifaceted protein
export pathway that is widely distributed in Gram-negative
Proteobacteria [1,2]. With a minimal functional requirement for
the products of at least 13 genes, this secretion machine rivals the
complexity of the more extensively characterized type III and IV
systems [3,4]. Among the conserved components of the T6SS are a
AAA+ family ATPase, ClpV, two proteins with sequence similarity
to the type IVB secretion proteins IcmF and DotU, TssM and TssL,
and several proteins with sequence or structural similarity to non-
filamentous phage proteins [5]. The latter group of proteins includes
Haemolysin co-regulated protein (Hcp) and Valine glycine repeat
protein G (VgrG), which bear structural similarity to the tail protein
of lambda phage (gpV) and the puncturing device of T4 phage
(gp27/gp5), respectively [6–8]. Hcp and VgrG proteins are exported
in a co-dependent fashion from nearly all T6SSs characterized to
date. In combination, these observations have led to a prominent
structure-function model in which the T6S apparatus resembles
outward facing phage on the bacterial cell surface [9].
Early investigations of the T6SS focused on its role in
modulating bacterial-host cell interactions. These efforts yielded
information about the genetic requirements for T6S function and
provided evidence that a subset of T6SSs influence pathogenesis
by specifically mediating bacterial interactions with eukaryotic
cells [10]. In addition to mediating host cell interactions, the T6SS
has been shown to regulate gene expression and contribute to
biofilm formation [11,12]. It is not currently understood how the
system mediates such diverse phenomena, nor is it known in all
cases whether the effects observed are a direct or indirect result of
its function.
Recently it has become clear that the T6SS plays a key role in
mediating interactions between bacterial cells [2]. This was first
observed in P. aeruginosa, where the Hcp secretion island I-encoded
T6SS (H1-T6SS) was shown to target an effector protein, Tse2
(type VI secretion exported 2), to other P. aeruginosa cells [13].
Recipient cells lacking a Tse2-specific immunity protein, Tsi2
(type VI secretion immunity 2), were found to be at a competitive
disadvantage relative to donor cells possessing Tse2. Although the
mechanism of action of Tse2 remains unknown, the fitness
advantage bestowed by the protein requires a functional T6SS in
the donor cell and close association of donor and recipient cells.
The H1-T6SS exports at least two additional effector proteins,
Tse1 and Tse3 [14]. These proteins are targeted by the T6SS to
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and thereby provide a competitive fitness advantage for P.
aeruginosa donor cells. P. aeruginosa protects its own cells from the
action of these toxic proteins by synthesizing cognate periplasmic
immunity proteins, Tsi1 and Tsi3.
Tsi2 differs from Tsi1 and Tsi3 in several respects. For instance,
Tsi2 is an essential protein in P. aeruginosa, whereas Tsi1 and Tsi3
are dispensable for growth [14]. This reflects the differences in the
subcellular sites of action of the associated cognate toxins. Because
the T6S export mechanism avoids periplasmic intermediates,
immunity proteins for periplasmically-targeted effectors (Tse1 and
Tse3) are required only for resisting intercellular self-intoxication.
Conversely, Tse2 appears to act in the cytoplasm; therefore, in
addition to resisting Tse2 delivered to the cytoplasm via
intercellular self-intoxication, Tsi2 is essential for protecting
against endogenous cytoplasmic intermediates of Tse2. Owing to
their localization in the same subcellular compartment, Tse2 and
Tsi2 are able to complex prior to toxin export. In the case of
Tse1–Tsi1 and Tse3–Tsi3, the physical separation of the toxins
(cytoplasmic) from their immunity proteins (periplasm) prevents
such interactions. This likely imparts a unique requirement for
Tse2 export – it must be recognized by the secretory apparatus in
the context of a protein complex. Since Tsi2 is not exported by
H1-T6SS, it must also be dissociated prior to or during the
secretion of Tse2. In this way, Tsi2 is analogous to specialized
dedicated secretion chaperones involved in the export of effectors
from other alternative secretion pathways such as the type III and
IV systems [3,15]. Secretion chaperones are known to function
critically both in stabilizing cognate effectors prior to export and in
targeting effectors to the secretion apparatus.
It is apparent that bacterial genomes possess an enormous
diversity of toxin-immunity modules outside of T6S-associated
Tse–Tsi pairs [16–18]. Perhaps the most abundant and thor-
oughly characterized of these are the toxin-antitoxin (TA) systems
[19,20]. Growing evidence supports a general role for TA systems
in resistance to stress and persister cell formation [21]. Type II TA
systems consist of a cytoplasmic toxin that is maintained–under
favorable conditions–in an inactive state by direct binding to a
specific cognate antitoxin protein. Upon activation of cellular
stress-response pathways, the antitoxin, which is typically less
stable than the toxin, is rapidly degraded by cellular proteases
including Lon (Long Form Filament), allowing the toxin to act on
its target(s). Toxins vary in their mechanism, however most act as
either ribosome-dependent or -independent mRNAses [22,23].
The properties of the Tse2–Tsi2 pair that make it unique
among T6S effector–immunity proteins are the same as those that
offer analogy to effector–chaperone and toxin–antitoxin systems.
In this report, we sought to ascertain the degree of similarity
between these systems by interrogating the structure and function
of Tsi2. Our results define properties of Tse2–Tsi2 that are shared
with both TA and effector-chaperone systems, however we find
that the Tse2–Tsi2 system is altogether functionally, structurally,
and mechanistically distinct.
Results
Tsi2 protects against Tse2-induced stasis
We have reported that P. aeruginosa donor cells capable of
delivering Tse2 by an active H1-T6SS to P. aeruginosa recipient
bacteria lacking tsi2 have a pronounced competitive fitness
advantage [13]. However, absolute colony forming units (CFU)
of competing bacteria were not determined in these experiments,
which precluded defining whether Tse2 causes cell death or stasis
in recipient cells when delivered by the T6SS. Lacking this
information, the physiological role of Tsi2 – the subject of our
current study – in the context of an interbacterial interaction was
also not known.
To investigate the role of Tsi2 in resisting T6S-dependent Tse2-
based intoxication, we monitored changes in donor and recipient
CFU during interbacterial competition experiments between P.
aeruginosa strains. Both donor and recipient strains were generated
in the P. aeruginosa DretS background. The deletion of retS relieves
tight negative posttransciptional regulation of the H1-T6SS and
reveals a robust T6S- and Tse2-dependent competitive fitness
advantage between strains. Recipient strains bore an additional
deletion of the tse2 tsi2 bicistron, which renders them sensitive to
Tse2. Both tse2 and tsi2 must be deleted in this strain, as the
deletion of tsi2 alone is lethal in the presence of tse2. Donor strains
were distinguished from recipients by chromosomal lacZ expres-
sion from the neutral attB site. Interestingly, we found that while
total CFU of the donor strain increased exponentially over the
course of the competition experiment, CFU of the recipient
remained constant (Figure 1A). Consistent with our earlier
findings, this inhibition of proliferation required tse2 in the donor
and the absence of tsi2 in the recipient (Figure 1B & 1C).
We considered three explanations for our finding that the
overall population of recipient cells lacking Tse2 immunity did not
change during competition experiments against donor cells
actively exporting Tse2 by the T6SS: 1) recipient cells are
efficiently targeted (approaching 100%) and Tse2 is always
bacteriostatic, 2) recipient cells are inefficiently targeted and
Tse2 is bactericidal, and 3) recipient cells are efficiently targeted,
but differentially affected by Tse2 (unaffected, growth-inhibited, or
killed). In the latter two scenarios, the balance between
proliferation and death (2), or between proliferation, non-
proliferation, and death (3), could produce the stable overall
population of recipient bacteria observed. For either of these
possibilities, we would expect to observe elevated cell death that is
Tse2-dependent in competition experiments between a donor
bacterium and a sensitive recipient. However, we found equivalent
fractions of dead cells when a sensitive strain was competed against
a donor strain capable of delivering Tse2 or one lacking Tse2
(Figure 1D). From these data, we conclude that recipient cells are
Author Summary
Bacterial species have been at war with each other for over
a billion years. During this period they have evolved many
pathways for besting the competition; one of the most
recent of these to be described is the type VI secretion
system (T6SS). The T6SS of Pseudomonas aeruginosa is a
complex machine that the bacterium uses to intoxicate
neighboring cells. Among the toxins this system delivers is
type VI secretion exported 2 (Tse2). In addition to acting
on competing organisms, this toxin can act on P.
aeruginosa; thus, the organism synthesizes a protein, type
VI secretion immunity 2 (Tsi2), which neutralizes the toxin.
In this paper we dissect the function and structure of Tsi2.
We show that although Tsi2 interacts with and stabilizes
Tse2 inside the bacterium, the toxin does not require the
immunity protein to reach the secretion apparatus. Our
structure of Tsi2 shows that the protein adopts a dimeric
configuration; however, we find that its dimerization is not
required for Tse2 interaction. Instead, our findings indicate
that Tse2 interacts with an acidic surface of Tsi2 that is
opposite the homodimer interface. Our results provide key
molecular insights into the process of T6 toxin secretion
and immunity.
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protects cells from stasis induced by Tse2.
Tsi2 is stable and directly interacts with Tse2
The substrates of many bacterial secretion pathways require
dedicated chaperones for their export. We hypothesized that in
addition to its immunity function, Tsi2 might also serve as a
dedicated chaperone for Tse2. Although our earlier work has
shown that Tse2 and Tsi2 interact in P. aeruginosa, whether the
proteins bind directly was not determined [13]. As a first step
toward investigating the involvement of Tsi2 in Tse2 export, we
probed for direct interaction between the proteins using an E. coli
bacterial two-hybrid (B2H) assay [24]. In the system we employed,
fusions of candidate interaction partners are made to a zinc-finger
DNA-binding protein, Zif, and the v subunit of RNA polymerase.
Association of the fusion proteins promotes transcription of a lacZ
reporter gene as described by Dove and colleagues [25]. The
broadly toxic nature of Tse2 is a complicating factor for analyzing
the protein in heterologous systems such as E. coli. Indeed, upon
induction of its synthesis from B2H vectors, we found that cellular
physiology was rapidly modified, obscuring interpretation of
results (data not shown). To facilitate the study of Tse2 in the
B2H, we used an allele of the gene encoding a non-toxic Tse2
variant, Tse2
T79A S80A (Tse2NT). A description of this mutant is
provided below. E. coli strains expressing Tsi2 C-terminally fused
to the vesicular stomatitis virus glycoprotein (VSV-G) epitope
followed by the Zif protein (Tsi2–V–Zif) and Tse2NT–v showed
significantly enhanced LacZ activity over control strains, indicat-
ing that Tsi2 and Tse2 directly interact (Figure 2A).
The interactions between dedicated secretion chaperones and
their effector substrates often enhance stability of the effector in
the bacterial cytoplasm [26]. However, if Tsi2 behaves analo-
gously to typical antitoxin components of TA modules, even in the
absence of stress it would be expected to have a shorter lifetime
than the toxin – leaving it unable to act directly in stabilizing Tse2
[27]. Therefore, prior to determining if Tsi2 influences the stability
of Tse2, we queried the relative stabilities of the two proteins in P.
aeruginosa. Western blot analyses of cells following treatment with
the protein synthesis inhibitor tetracycline showed an almost
complete loss of intact Tse2–V after one hour (Figure 2B).
However, no significant decrease in Tsi2–V levels was observed in
the cells over the same time period. This was not the result of Tsi2
stabilization by its C-terminal VSV-G fusion, as an N-terminal
VSV-G-fused Tsi2 (V–Tsi2) displayed similar stability (Figure S1).
The finding that Tsi2 is more stable in cells than its cognate toxin
motivated us to further investigate its potential chaperone activity.
Tsi2 stabilizes Tse2 but is not required for effector
secretion
Next we sought to ascertain the influence of Tsi2 on the stability
of Tse2 in P. aeruginosa. Since Tse2 is toxic in cells lacking Tsi2, this
experiment required the use of a non-toxic variant of Tse2.
Furthermore, it was necessary that this variant bore only minimal
perturbations, such that its stability and overall structure
accurately reflected that of the native protein. In light of the
additional objective of the study to probe the involvement of Tsi2
in Tse2 secretion, we added the requirement that the non-toxic
variant was competent for export through the H1-T6S apparatus.
Figure 1. Tsi2 protects against stasis induced by Tse2 delivered via the T6SS. (A–C) Growth competition assays between the indicated
donor (squares) and recipient (circles) P. aeruginosa strains. For CFU enumeration, strains were distinguished by the presence or absence of LacZ
activity. (D) Quantification of dead cells from competition experiments in A and C at the indicated time point (arrow).
doi:10.1371/journal.ppat.1002613.g001
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haveso far failed to identify sequence motifsthat would facilitate the
prediction of residues essential for its function. Therefore, we
adopted a scanning mutagenesis approach for defining minimal
inactivating mutations. Using site-directed mutagenesis, we gener-
ated 15 tse2 alleles encoding adjacent double alanine substitutions at
ten amino acid intervals along the length of the protein. In the four
cases wherein one of these positions already encoded an alanine,
only one substitution was made. Toxicity of the mutant alleles was
determined by monitoring the effect of their ectopic expression on
the growth of PAO1 Dtse2 Dtsi2. Two alleles, tse2
T79A S80A –V
(tse2NT–V) and tse2
V109A K110A–V, displayed a marked decrease in
cytotoxicity relative to the wild-type protein (Figure 3A). Western
blot analysis showed that the mutant proteins accumulated to levels
similar to those of the wild-type protein, suggesting that their lack of
toxicity is due to inactivation of the toxin rather than poor
expression or decreased stability (Figure S2).
The sequence and structural determinants for effector export by
the T6SS remain unresolved; therefore, we proceeded to empiri-
cally determine whether the non-toxic Tse2 variants retained H1-
T6SS-dependent secretion. Expression plasmids directing the
synthesis of Tse2NT–V and Tse2
V109A K110A–V, or Tse2–V were
introducedintoP.aeruginosaDretSDtse2.Thegenesinactivatedinthis
strain lead to constitutive export of effectors by the H1-T6SS (DretS)
and avoid potential competition between native Tse2 and the
ectopically-produced protein for the secretory apparatus (Dtse2). As
an additional control, we also transformed a plasmid directing the
synthesisof Tse2–Vinto DretS Dtse2 DclpV1. The clpV1 gene encodes
a AAA+ family ATPase that is an important determinant of effector
export by the H1-T6SS. Consistent with our earlier finding that
Tse2 is a substrate of the H1-T6SS, the wild-type protein was
detected in concentrated culture supernatants in a manner
dependent on clpV1 (Figure 3B). The level of secreted Tse2NT–V
was similar to that of the wild-type protein, whereas secretion of
Tse2
V109A K110A–V was not detected. From these data, we conclude
that Tse2NT is a non-toxic substrate of the H1-T6SS.
With a non-toxic and secreted Tse2 mutant in hand, we were
able to test the involvement of Tsi2 in Tse2 stability and secretion
by the H1-T6SS. The contribution of Tsi2 to Tse2 stability was
determined by comparing the lifetime of Tse2NT–V when co-
expressed in cells with Tsi2–V versus when expressed in cells
devoid of Tsi2. For co-expression, Tse2–V and Tsi2–V were
produced in their native bicistronic configuration under the
control of an inducible promoter. Our data showed that the
presence of Tsi2–V significantly extends the lifetime of Tse2NT–V
in P. aeruginosa. In the absence of Tsi2–V, intact Tse2NT–V was not
detected beyond 15 minutes following the inhibition of protein
synthesis; however, it persisted for 60 minutes in the presence of
the immunity protein (Figure 3C). The short cellular lifetime of
Tse2–V was not due to either its fusion to the VSV-G epitope tag
nor to secretion via the H1-T6SS (Figure S1).
To determine the contribution of Tsi2 to Tse2 export by the
H1-T6SS, levels of Tse2NT–V in culture supernatants from P.
aeruginosa DretS strains with or without tsi2 were compared using
quantitative western blotting. This analysis clearly demonstrated
that Tsi2 is not required for Tse2 secretion by the H1-T6SS
(Figure 3D). Therefore, despite the direct interaction of Tsi2 with
Tse2, and the role of this interaction in stabilizing intracellular
Tse2, Tsi2 appears to have no role in targeting Tse2 to the
secretion apparatus.
1.00 A ˚ X-ray crystal structure of a Tsi2 dimer
To gain additional mechanistic insights into Tsi2 function, we
solved its X-ray crystal structure to a resolution of 1.00 A ˚ (Table
S1, Figure 4A). Phasing of the structure was obtained using the
multiwavelength anomalous diffraction method on a 1.68 A ˚
resolution dataset collected from a crystal containing selenome-
thionine-substituted, C-terminal hexahistidine-tagged Tsi2 (Tsi2–
H6) [28]. A molecular model fit to a 1.68 A ˚ resolution electron
Figure 2. Tsi2 is stable and directly interacts with Tse2. (A)
Analysis of Tse2–Tsi2 interaction using the B2H assay. Genes fused in-
frame to RNAP–v and Zif are indicated. The mvaT gene codes for a
protein previously shown to homo-oligomerize and activate lacZ
expression in this system. Dashes indicate vectors lacking inserts. A
non-toxic allele of tse2 (tse2
T79A/S80A (tse2NT)) was utilized in this and all
subsequent B2H assays wherein Tse2 interactions were probed. (B)
Western blot analysis of Tse2 and Tsi2 stability in P. aeruginosa Dtse2
Dtsi2. The genes were co-expressed in their native bicistronic
configuration from the indicated inducible ectopic expression vector.
Tetracycline (Tet) was added at time zero to interrupt protein synthesis.
Equivalent samples were removed at the indicated times and probed
for the presence of each protein. RNA polymerase (RNAP) is included as
a loading control.
doi:10.1371/journal.ppat.1002613.g002
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collected from an isomorphous crystal of native Tsi2–H6. Two
monomers interacting through extensive contacts were modeled
into the crystallographic asymmetric unit (Figure 4B). Each Tsi2
monomer consists of two large a-helices (a1, amino acids 4–26
(based on monomer A); a2, 30–62) arranged as an anti-parallel
coiled-coil connected by a short turn (T1, 27–29) (Figure 4C). The
remaining C-terminal end of the protein is composed of a short
helical segment (a3, 67–72) located between two extended loops
(L1 and L2).
In the observed Tsi2 dimer, the long axes of the two monomers
are arranged approximately perpendicular to each other and the
molecules pack via their coiled-coils. This interaction involves a
large (725 A ˚ 2, 13% total surface area) and predominately
hydrophobic (68%) surface area, indicative of a physiologically
relevant interface. In agreement with this, the molecular weight of
purified Tsi2 measured by gel filtration chromatography was
found to closely approximate that of the dimer (calculated,
19.16 kDa; measured, 19.46 kDa), and we observed strong
interaction between Tsi2 monomers using the B2H assay
(Figure 4D and Figure S3). Superimposition of the Tsi2 monomers
showed that overall the two subunits adopt highly similar
structures (Ca r.m.s.d, 1.1 A ˚).
An acidic surface of Tsi2 mediates interaction with Tse2
As Tse2 has proven recalcitrant to in vitro reconstitution, a direct
biochemical study of the Tse2–Tsi2 interface has not been feasible.
As an alternative strategy, we mutagenized 27 solvent-accessible
Tsi2 residues to alanine and probed for effects on toxin immunity
as a proxy for functional interaction with Tse2. None of these
substitutions, nor a truncation of Tsi2 lacking residues C-terminal
of a3, showed a measurable impact on Tse2 interaction (Figure
S4). We did not attempt to analyze more extensive truncations of
Tsi2, as removing residues from a1o ra2 would likely disrupt its
overall fold. From these results we conclude that the interaction of
Tse2 with Tsi2 does not require the C-terminal loops and helix of
Tsi2, and that interaction is resilient to minor perturbations of the
Tsi2 surface.
The difficulty we encountered rationally dissecting the Tse2
binding site of Tsi2 led us to pursue a genetic screening strategy.
The screen we designed exploited our ability to detect Tsi2
homodimerization and Tse2–Tsi2 association using the B2H
(Figure 5A). A random PCR-generated mutant library of tsi2 was
inserted into the pACTR::V–zif B2H vector such that clones
lacking nonsense mutations would generate N-terminal fusions to
V–Zif (Tsi2*–V–Zif). Next, the B2H was used to identify those
pACTR::tsi2*–V–zif clones that did not activate lacZ expression
when co-transformed into cells expressing Tse2NT–v. After
cultivation of positive clones, pACTR::tsi2*–V–zif plasmids were
isolated, pooled and transformed into cells expressing Tsi2–v.A t
this stage, clones of pACTR::tsi2*–V–zif that retained homotypic
interaction, and therefore expressed high levels lacZ in the
presence of Tsi2–v, were selected for further characterization.
While this second stage of our screen was critical for removing
Figure 3. Tsi2 stabilizes Tse2, but is dispensable for Tse2 export by the H1-T6SS. (A) Identification of non-toxic Tse2 double-alanine
substitution mutants. Photographs of P. aeruginosa Dtse2 Dtsi2 colonies transformed with an empty vector (pPSV35-CV) or vectors containing the
indicated tse2 alleles grown under inducing (+) or non-inducing (2) conditions. (B) Western blot analysis of wild-type Tse2 and non-toxic Tse2
variants identified in panel A in the cell-associated (Cell) and supernatant (Sup) fractions of the indicated P. aeruginosa strains. The tse2 alleles were
ectopically expressed from pPSV35-CV. (C) Analysis of Tse2NT stability in P. aeruginosa Dtse2 Dtsi2 following the inhibition of protein synthesis by the
addition of Tetracycline (Tet) at time zero in the presence (top blots) and absence (bottom blots) of Tsi2. Genes were ectopically expressed from
pPSV35-CV. The native tse2 tsi2 bicistron configuration was utilized for tse2NT-tsi2 co-expression. Equivalent samples were removed at the indicated
times and probed for the presence of each protein. RNA polymerase (RNAP) is included as a loading control. (D) Western blot analysis of Tse2NT in the
cell-associated (Cell) and supernatant (Sup) fractions of the indicated P. aeruginosa strains. Values below the blots correspond to average values of
secreted Tse2NT based on band densitometry measurements from three independent experiments (% normalized to parental 6 standard deviation).
doi:10.1371/journal.ppat.1002613.g003
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and mutations that abrogated tsi2 expression, we are also aware of
the caveat that it systematically eliminated the potential to recover
tsi2* clones that affect both Tse2 and Tsi2 interaction. This issue is
addressed below.
Despite screening approximately 20,000 Tsi2* clones, we were
able to identify only one single amino acid substitution, Tsi2
E38K,
that specifically abrogated Tse2 interaction when reconstructed
and retested in the B2H (Figure 5B). Interestingly, modeling of the
electrostatic surface potential of Tsi2 showed that residues in the
vicinity of Glu38, including Asp23, Asp45 and Asp49, generate a
prominent negatively charged surface feature (Figure 5C). Based
on these findings, we hypothesized that this acidic patch on the
surface of Tsi2 contributes directly and critically to Tse2 binding.
Although our structure of Tsi2 indicates that Glu38 does not
mediate intramolecular interactions, we sought to rule-out the
possibility that its non-conservative substitution with Lys perturbs
native Tsi2 structure and indirectly leads to a loss of Tse2 binding.
To this end, we purified Tsi2
E38K–H6 and Tsi2–H6 from E. coli
and compared their secondary structure by circular dichroism
spectroscopy (CD). Consistent with our X-ray crystal structure of
Tsi2, the CD spectrum of the wild-type protein showed strong
helical character (Figure S5). The CD spectrum of Tsi2
E38K–H6
displayed close agreement with the wild-type, suggesting that the
Lys substitution does not significantly alter Tsi2 structure (Figure
S5).
Tsi2 is a strongly acidic protein (calculated isolectric point, 4.1)
with several solvent-exposed negatively charged amino acids
located outside of the Glu38-containing acidic surface patch
(Figure 5C). To further investigate the specific involvement of this
region on Tse2 interaction, we compared the effects of
substituting Glu and Asp with Lys within, and outside of, its
boundary. In total, we constructed nine additional lysine
substitution mutants: three within the acidic patch (D23K,
D45K, D49K) and six outside (D30K, E36K, E56K, D69K,
E73K, E74K). Using the B2H assay, each Tsi2 substitution
mutant was probed for its capacity to both dimerize and associate
with Tse2. The nine variants expressed to similar levels as the
wild-type protein, and, as expected, none of the substitutions
affected Tsi2 dimerization (Figures 5B and S6). Interestingly,
while substitutions outside of the acidic patch had no effect on
Tse2 interaction, Tsi2 bearing a lysine at position 45 (Tsi2
D45K),
located within the acidic patch, was incapable of binding to Tse2
(Figure 5B). CD spectroscopy confirmed that Tsi2
D45K–H6
Figure 4. Crystal structure of a Tsi2 dimer. (A) Representative electron density (2Fo2Fc coefficients) of the Tsi2 structure. Numbers correspond
to amino acid positions in the sequence of Tsi2. Residues shown are from Monomer A of the dimer (carbon, yellow; nitrogen, blue; oxygen, red). (B)
Ribbon representation of the Tsi2 crystal structure (PDB code: 3RQ9). Protomers of the observed Tsi2 dimer are differentially colored (monomer A,
yellow; monomer B, blue) and secondary elements of monomer A are labeled. (C) Schematic depicting the secondary structure of Tsi2. Secondary
structure designations defined in the text are provided and key amino acids are highlighted with symbols (diamond, Glu38; circle, Asp45; asterisk,
Ala47). (D) B2H analysis of Tsi2 dimerization. Genes fused in-frame to RNAP–v and Zif are indicated.
doi:10.1371/journal.ppat.1002613.g004
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S5). Surprisingly, no effect on Tse2 binding was caused by the
Asp23Lys or Asp49Lys substitutions, suggesting that the residues
critical for Tse2 binding within the acidic patch of Tsi2 are Glu38
and Asp45. The observed lack of Tse2 binding by Tsi2
E38K–V
and Tsi2
D45N–V was also reflected in the immunity properties of
the proteins. We observed that both proteins fail to rescue Tse2-
based toxicity when expressed in E. coli (Figure 5D).
The prominent role of Glu38 and Asp45 in Tse2 binding is
further supported by the results of additional mutagenesis studies.
Conservative substitutions introduced at these positions displayed
a synergistic effect on Tse2 binding. Neither Tsi2 substitutions
Glu38Gln nor Asp45Asn alone had a measurable impact on Tse2
interaction, however their combination reduced Tse2 binding by
approximately 50%, as determined using the B2H assay
(Figure 5E). From these data, we conclude that Glu38 and
Figure 5. An acidic patch of Tsi2 mediates interaction with Tse2 and is required for toxin immunity. (A) Schematic summarizing the
genetic screen conducted to define Tse2 binding determinants of Tsi2. In Step 1, tsi2 mutants (tsi2*) encoding variants that do not interact with Tse2
are retrieved by selecting colonies of low LacZ activity (arrowhead and dashed box). In Step 2, tsi2 mutants encoding variants that retain interaction
with Tsi2 are retrieved by selecting colonies of containing high LacZ activity (arrowhead and dashed box). (B) Top – B2H analysis of wild-type Tsi2 and
Tsi2
E38K interaction with Tsi2 and Tse2. Genes fused in-frame to RNAP–v and Zif are indicated. Bottom – Western blot analysis of the expression of
tsi2–V–zif alleles within the indicated strains. (C) Molecular surface representation of the Tsi2 dimer colored by electrostatic potential (red, acidic; blue,
basic). The border of the acidic patch is outlined for clarity. Acidic surface residues substituted with lysine and tested for Tse2 and Tsi2 binding are
indicated. (D) Growth of E. coli stains expressing tse2 alone, or co-expressing tse2 with the indicated allele of tsi2–V, under non-inducing (2IPTG) or
inducing (+IPTG) conditions. (E) Top – B2H analysis of conservative Tsi2 acidic patch substitutions on homotypic (Tsi2) and heterotypic (Tse2)
interactions. Genes fused in-frame to RNAP–v and Zif are indicated. Bottom – Western blot analysis of the expression of tsi2–V–zif alleles within the
indicated strains.
doi:10.1371/journal.ppat.1002613.g005
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Furthermore, the substantial loss of Tse2 binding observed upon
mutation of these residues to glutamine and asparagine,
respectively, suggests that the Tse2–Tsi2 interface is stabilized in
part by electrostatic interactions.
Dimerization of Tsi2 is not required for interaction with
Tse2
As mentioned above, one caveat of our screen for Tse2-binding
determinants of Tsi2 is that it excluded those mutations that also
disrupt Tsi2 dimerization. It is conceivable that disruption of the
Tsi2 dimer has a generally negative impact on Tse2 binding. Such
a scenario could explain the difficulty we encountered in
identifying Tsi2 substitutions that lose Tse2, but not Tsi2
interaction. To address this issue, we probed the requirement for
Tsi2 dimerization in the interaction of the protein with Tse2.
Inspection of the dimer interface permitted the identification of
several candidate non-conservative single amino acid substitutions
that we predicted could destabilize the Tsi2 dimer. To minimize
the probability that our mutations – if successful in disrupting the
Tsi2 dimer – would not disrupt Tse2 binding, we limited our
mutagenesis to single substitutions. Our initial attempts focused on
Arg18 and Glu21, which form a network of polar intersubunit
interactions at the origin of the non-crystallographic two-fold
rotation axis relating the two subunits in the dimer (Figure 6A).
However, B2H analyses of alanine substitution mutants at these
positions showed that disruption of this network does not
significantly destabilize the overall dimer interface (Figure S7).
Together these residues constitute the most significant polar
intersubunit contacts, thus we concluded that interfering with
hydrophobic interactions would be necessary to disrupt the Tsi2
dimer.
Hydrophobic interactions between Tsi2 monomers are exten-
sive. To increase the likelihood that single amino acid substitutions
in non-polar residues at this interface resulted in significant
perturbation, we replaced selected residues with the large polar
Figure 6. Homodimerization of Tsi2 is not critical for Tse2–Tsi2 interaction. (A) Ribbon representation of the Tsi2 dimer interface. Amino
acids positions substituted non-conservatively to disrupt the dimer interface are labeled on monomer A and shown in stick representation. (B) Top –
B2H analysis of homodimerization of the indicated Tsi2 dimer interface substitution variants. Genes fused in-frame to RNAP–v and Zif are indicated.
Bottom – Western blot analysis of the expression of tsi2–V–zif alleles within the indicated strains. (C) Western blot analysis of Tsi2–biotin–maleimide
conjugates. Equal concentration of purified Tsi2 variants (10 mM) were reacted for the indicated time periods with 10 mM of a biotin-maleimide
conjugate. (D) B2H analysis of the interaction between wild-type Tsi2 and Tsi2
A47Q with Tse2. Genes fused in-frame to RNAP–v and Zif are indicated.
(E) Growth of E. coli stains expressing tse2 alone, or co-expressing tse2 with the indicated allele of tsi2, under non-inducing (2IPTG) or inducing
(+IPTG) conditions.
doi:10.1371/journal.ppat.1002613.g006
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phobic interface residues (all .90% solvent inaccessible), Val10,
Cys14, and Ala47, were selected, substituted with glutamine, and
tested for homodimerization (Figure 6A). Of the three mutant
proteins, only Tsi2
A47Q displayed decreased activity in the B2H
(Figure 6B). Levels of this protein were similar to the other mutant
proteins and the wild-type, consistent with the diminished activity
observed specifically resulting from a failure to efficiently
homodimerize. As an independent measure of dimer formation
by Tsi2
A47Q, we employed an in vitro cysteine accessibility assay.
This assay is based on our observations that Tsi2 possesses only
one cysteine residue, and that this amino acid is solvent
inaccessible at the dimer interface (Figure 6A). Destabilization of
the interface is expected to increase the reactivity of the Cys14
sulfhydryl side chain to small soluble maleimide-containing





controls, and incubated the proteins with biotin-maleimide.
Reactions were separated by SDS-PAGE and protein-biotin-
maleimide conjugates were visualized by probing with Neutravi-
din-HRP. Consistent with our B2H data, Tsi2
A47Q–H6 reacted
more rapidly than the wild-type protein or Tsi2
E21A–H6
(Figure 6C). Tsi2
C14A–H6 displayed no observable reactivity
under these conditions, indicating that the products observed
were specifically due to the reactivity at this site. Taken together
with our B2H data, these data strongly suggest that the native Tsi2
dimer interface is significantly disrupted in Tsi2
A47Q.
With a Tsi2 dimer-defective variant in hand, we next sought to
measure the impact of dimer disruption on heterotypic interac-
tions of Tsi2 with Tse2. First, using the B2H assay, we observed no
significant difference between Tsi2–V and Tsi2
A47Q–V binding
with Tse2 (Figure 6D). As a second, functional measure of Tse2–
Tsi2 interaction, we also tested the capacity of Tsi2
A47Q to provide
immunity to Tse2. Our data showed that Tsi2
A47Q–V, like Tsi2–
V, provides full protection against Tse2-based toxicity in E. coli
(Figure 6E). In total, these data show that the Tse2–Tsi2
interaction is insensitive to the oligomeric state of Tsi2. Taken
together with our screening data, we conclude that the regions of
Tsi2 important for Tsi2 homotypic versus Tse2 heterotypic
interactions are topologically distinct; Tse2 binding occurs at the
face of Tsi2 opposite the site of homodimerization.
Discussion
This study has shown that the Tse2–Tsi2 system has a unique
set of properties that do not neatly conform to existing paradigms
for toxin-antitoxin and effector-chaperone systems. For example,
unlike canonical antitoxins, Tsi2 is more stable than its cognate
toxin. This may reflect different physiological functions of the two
systems. While the roles of TA systems are variable, and in
certain instances remain a matter of debate, it is well established
that they serve important functions in gene maintenance and
response to stress [20]. For both of these functions, the activity of
the TA system involved is mediated by modulation of toxin
activity through antitoxin degradation. Our finding that Tsi2
stability greatly exceeds that of Tse2 suggests that this system has
not evolved to conditionally release the toxin. Therefore,
assuming an adequate expression level, P. aeruginosa strains
endowed with tsi2 are likely to possess stable, non-dynamic
immunity to growth inhibition by Tse2. In this way, Tsi2 is more
akin to certain colicin immunity proteins, which bind their
cognate toxin with extraordinary affinity and provide complete
protection against both endogenous and xenogenous cognate
toxin [17,29].
Despite the functional disparities between the Tse2–Tsi2 and
TA systems, they do possess notable parallels. One common
property of TA systems is that the components have strongly
opposing electrostatic character [19]. In the majority of instances,
the antitoxin is more acidic than its cognate toxin. This is also the
case for the Tse2–Tsi2 system, wherein Tsi2 is highly acidic and
the difference in the calculated isoelectric points of the two
proteins is 2.6. This analogy holds, and is even more striking, when
one considers the other Tse-Tsi pairs. The differences in toxin and
immunity isoelectric points are greater in magnitude for these
proteins (Tse/i1, 4.1; Tse/i3, 3.6), and in both cases the immunity
proteins are acidic. A second shared physical attribute of TA and
the Tse2–Tsi2 systems is that their antitoxin and immunity
components, respectively, display modularity in their homotypic
and heterotypic interactions. Although type II antitoxins are
highly diverse at the sequence level, recent biochemical and
structural analyses of these proteins indicate that they often exist as
dimers and, despite their small size, homomeric contacts occur at a
site physically removed from the site of cognate toxin interaction
[30]. Our discovery that amino acids positions of Tsi2 critical for
Tse2-binding reside on the face of the protein opposite from those
involved in its homodimerization, taken together with our ability
to readily generate specific loss-of-function mutations at either of
these sites, strongly suggest an analogous configuration of the
Tse2–Tsi2 complex.
We found that co-expression of tsi2 with tse2 leads to a
significant increase in the stability of the toxin, suggesting that the
two proteins closely interact. Despite this, cells lacking Tsi2 have
no detectable defect in Tse2 secretion, indicating that Tsi2 does
not–in addition to its immunity properties–play a role in targeting
Tse2 to the secretion apparatus. The specialization of Tsi2 as an
immunity protein is in line with our current understanding of the
function of other T6SS effector immunity proteins, Tsi1 and Tsi3.
These proteins reside in the periplasm and therefore are
unavailable to assist in ushering their cognate toxins to the H1-
T6SS [14]. This leaves open the question of how T6S effectors are
recognized by the apparatus. One possibility is that effectors are
bound by yet unidentified specialized secretion chaperone(s). In
this case, such a protein might remove Tse2 from the Tse2–Tsi2
complex prior to export. Since we observed no impact of Tsi2 on
Tse2 secretion, we would expect that such a protein would either
bind Tse2 with higher affinity than Tsi2, or that it would bind a
region of Tse2 not involved in Tsi2 binding and target the protein
to the secretion machine, where Tsi2 would be readily removed.
An alternative explanation for our finding that Tsi2 has no
impact on Tse2 export is that the Tse proteins are exported co-
translationally. In this model, Tsi2, like Tsi1 and Tsi3, might be
present largely to protect against cognate Tse proteins arriving in
trans via the T6SSs of adjacent bacteria. Co-translational export of
the Tse proteins could also help reconcile how periplasmic
effectors, in particular Tse1, which possess numerous cysteine
residues, avoid misfolding in the reduced cytoplasmic environ-
ment. Based on this model, one would predict that the H1-T6SS
and its effectors would be tightly co-regulated. In P. aeruginosa,
expression of tse and HSI-I genes (encode the H1-T6S apparatus)
are coordinately co-regulated by the Gac/Rsm pathway [7,31].
Interestingly, this pathway stringently controls expression at the
posttransciptional level, which would appear logical if a build-up
of cytoplasmic effector was undesirable.
Teng and colleagues recently reported the crystal structure of
the N-terminal three-helix bundle (Habc) domain of the yeast
SNARE (soluble N-ethylmaleimide-sensitive factor activating
protein receptor) Vti1p bound to its epsin-like adaptor protein
Ent3p [32]. According to analyses using DALI, the Vti1p Habc
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databank (Z score, 7.8; Ca r.m.s.d, 1.2 A ˚). Specifically, a close
match of the length and curvature of the two large helices of Tsi2
to helices A and B of the Habc domain leaves these regions of the
two structures nearly indistinguishable (Figure 7). Not only are
these proteins structurally related, they also appear to interact with
binding partners in a spatially and chemically similar fashion. Two
acidic residues located on helix B of the Habc domain, Glu42 and
Asp46, were identified by Teng and colleagues as critical
determinants of Ent3p binding. Substitution of either residue with
arginine severely disrupted the interaction of Vti1p with Ent1p
and led to mislocalization of Vti1p in yeast [32]. Interestingly, in
an overlay of the two structures, these residues are found in close
proximity to the acidic residues of Tsi2 discovered in our study to
mediate Tse2 interaction (Figure 7). Although the simple structure
of Tsi2 necessarily reduces confidence in interpreting the
significance of structural similarity to the protein, we find the
extent of structural and functional similarity between Tsi2 and the
Habc domain striking. Our overall limited understanding of T6S
makes it difficult to reconcile the relatedness of Tsi2 to the Habc
domain, however it is worth noting that Tsi2 is now the second
T6S protein shown to possess structural homology to an N-
terminal regulatory domain of a SNARE protein. We recently
reported that TagF, a negative posttranslational regulator of the
T6SS, displays significant similarity to the N-terminal longin
domain of Sec22b [33]. This domain has no structural homology
to the Habc domain, however both can function analogously in
directing subcellular localization by mediating interactions with
adaptor proteins [34]. It will be of interest to determine the
evolutionary mechanisms underlying the relationship between
Tsi2 and TagF and proteins involved in vesicle trafficking.
The structure of Tsi2 marks an important first step toward a
complete molecular characterization of the Tse2–Tsi2 T6S toxin-
immunity pair. However, many key outstanding questions remain.
Foremost among these remains the mechanism of action of Tse2.
Our analysis of the effects of Tse2 on P. aeruginosa cells during
intraspecies competition suggests that the protein acts efficiently
and specifically to cease growth, and avoid killing targeted cells.
Such effects have been observed for TA system toxins that act by
cleaving mRNA, such as RelE [35]. Strong evidence that Tse2
also functions as a ribonuclease is lacking, however there are
noteworthy indications. For example, the Phyre (Protein Homol-
ogy/AnalogY Recognition Engine) structure prediction algorithm
reports similarity between Tse2 and enzymes that bind and
hydrolyze nucleic acids [36]. We found that an acidic patch of
amino acids located on the surface of Tsi2 mediates interaction
with, and immunity against Tse2. If like most antitoxins, Tsi2
inhibits its cognate toxin by active site occlusion, it is conceivable
that the negatively charged character of Tsi2 could engage basic
residues of Tse2 that would otherwise participate in nucleic acid
binding [37].
Materials and Methods
Plasmid and strain construction
Pseudomonas aeruginosa strains used in this study were derived
from the sequenced strain PAO1 [38]. P. aeruginosa strains were
grown on Luria-Bertani (LB) media at 37uC supplemented, when
appropriate, with 30 mg/ml gentamycin, 25 mg/ml irgasan,
40 mg/ml X-gal, and stated concentrations of Isopropyl b-D-1-
thiogalactopyranoside (IPTG). Escherichia coli strains used in this
study included DH5a for plasmid maintenance, SM10 for
conjugal transfer of plasmids into P. aeruginosa, and BL21 pLysS
for expression of Tse2 and Tsi2. The tse2, tsi2 genes and tse2 tsi2
and tse2–vsv-g tsi2 bicistronic sequences were PCR-amplified from
P. aeruginosa genomic DNA and cloned into pPSV35CV [13],
pET29b+ and pET21a+ vectors (Novagen). Site-directed mutants
of tsi2 and tse2 were generated using either QuickChange
(Stratagene) or Kunkel mutagenesis procedures [39]. Chromo-
somal fusions and in-frame gene deletions were generated as
described previously and were verified by DNA sequencing [7,40].
The DHSI-I strain was constructed such that all sequence between
nucleotide 2015 of PA0074 (ppkA) and nucleotide 754 of PA0091
(vgrG1) were deleted.
Growth competition assays
P. aeruginosa cultures were grown overnight at 37uC in LB broth
containing 0.01% L-arabinose. In each experiment, the donor
strain contained lacZ inserted at the neutral phage attachment site
[41]. LacZ-labeled donor and non-labeled recipient strains were
mixed at a ratio of 1:1 and spotted onto a 0.2 mm nitrocellulose
membrane (Whatman) on a 3% LB agar plate containing 0.2% L-
arabinose. Competitions were incubated at 37uC and harvested at
the indicated time points by resuspending bacterial cells in LB and
plating onto LB plates containing 40 mg/ml X-gal for CFU
enumeration.
Live/dead staining of bacterial cells
Growth competition assays of P. aeruginosa DretS and DretS Dtse2
against P. aeruginosa DretS Dtse2 Dtsi2 were performed on filters as
described above. At 4 hrs after initiating the experiment, the filters
were removed from agar plates and resuspended in 3 ml LB broth.
The cells were collected by centrifugation, washed once with 16
phosphate buffered saline (PBS) and resuspended in 100 ml PBS.
The bacterial suspension was stained with the LIVE/DEAD
BacLight Bacterial Viability Kit (Molecular Probes) according to
the protocol of the manufacturer. Viability was measured using a
fluorescence microscope equipped with FITC and mCherry filters.
The ratio of live/dead cells was determined by calculating the
green/red fluorescent cells for 12 random fields per competition.
Three independent experiments were performed.
Figure 7. Tsi2 shares structural similarity with the N-terminal
Habc domain of the Vti1p SNARE protein. Superimposition of the
N-terminal Habc domain (blue; residues 3–60, helix c not shown for
clarity) with the coiled coil region of Tsi2 (yellow; residues 3–63). Acidic
amino acids implicated in heterotypic protein interactions are depicted
using stick representation.
doi:10.1371/journal.ppat.1002613.g007
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C-terminal hexahistidine-tagged Tsi2 (Tsi2–H6) proteins were
overexpressed in E. coli BL21 pLysS. Overnight cultured cells were
back-diluted 1:1000 into fresh 26Yeast Tryptone (YT) media or
defined SelenoMet medium base and SelenoMet nutrient mix
medium (Athena Enzyme Systems). Expression was induced at an
OD600 of 0.5 with 0.1 mM IPTG for 16 hrs. at 20uC. Cells were
harvested by centrifugation (80006 g; 20 min, 4uC) and
resuspended in lysis buffer [50 mM Tris-HCl, pH 7.5, 0.5 M
NaCl, 1% (v/v) Triton X-100, 5% (v/v) glycerol, 1 mM DTT,
and protease inhibitor cocktail (Roche Diagnostics)]. Tsi2–H6 was
purified by affinity chromatography using a HisTrap FF column
(GE Healthcare) followed by size-exclusion chromatography on a
HiPrep 16/60 Sephacryl S-200 high-resolution column (GE
Healthcare) using the AKTA Explorer FPLC System. Purified
proteins were stored in a buffer containing 50 mM Tris-HCl
pH 7.5, 500 mM NaCl, 1 mM DTT, and 5% (w/v) glycerol and
dialyzed into a buffer containing 5 mM Tris-HCl pH 7.5, 5 mM
NaCl, and 1 mM DTT for crystallization.
Crystallization, structure solution, and structure analysis
Crystals of Tsi2-H6 were grown at 25uC by hanging drop vapor
diffusion. An equal volume of 10 mg/ml protein sample was
mixed with the crystallization solution (0.1 M sodium acetate,
pH 5.0 and 8% polyethylene glycol (PEG) 4000). Crystals were
cryo-protected in reservoir solution containing 25% PEG 4000
and flash frozen in liquid nitrogen. Diffraction data were collected
at the Lawrence Berkeley National Laboratory Advanced Light
Source (ALS) Beamline 8.2.1 (University of California, Berkeley).
Data were reduced using HKL2000 [42]. Phases were obtained
experimentally with data obtained from selenomethionine-substi-
tuted Tsi2-H6 for structure solution by multi-wavelength anom-
alous dispersion (MAD) using the SOLVE program [43]. The final
model was built by iterative model building and maximum
likelihood refinement with Refmac-5 [44]. Finally, 123 well-
defined water molecules were added, and refinement was
continued until the R-value converged to 0.144 (Rfree=0.176)
for all reflections to 1.00 A ˚ resolution. The CCP4 [45] suite and
XtalView [46] were used for crystallographic calculations.
Molecular figures were generated with PyMOL [47] and CCP4
Molecular Graphics [48]. The model was validated using
MolProbity [49]. All residues in the final model lie within allowed
regions of a Ramachandran plot and 99.4% lie within the
Ramachandran favored region. The crystal structure and structure
factors have been deposited in the Protein Data Bank (PDB entry
3RQ9) [50].
Bacterial two-hybrid analysis
Tse2 and Tsi2 derivatives were cloned into pBRGP–v and
pACTR–V–zif plasmids [25,51]. The pBRGP::tsi2–v and
pBRGP::tse2NT–v derivatives direct the synthesis of Tsi2 or Tse2
wild-type and mutant alleles as N-terminal fusions to the v subunit
of E coli RNAP. Plasmid pACTR::tsi2– V–zif directs the synthesis
of the Tsi2-VSV-G fusion to the N-terminus of the zinc finger
DNA-binding domain of murine Zif268 (Zif). The tsi2 gene was
mutagenized randomly by PCR with Taq DNA polymerase. A
pool of plasmids encoding the resulting tsi2 mutants were ligated
into the pACTR– V–zif plasmid and transformed into DH5a-F9IQ
cells. All resulting transformants were pooled for plasmid isolation.
Pooled plasmids were co-transformed with pBRGP::tse2NT–v into
KDZif1DZ competent cells and plated onto LB plates containing
12.5 mg/ml tetracycline, 150 mg/ml carbenicillin, 50 mg/ml kana-
mycin, 40 mg/ml X-gal, and 500 mM Phenylethyl-b-D-galactosi-
dase (tPEG). LacZ negative (white) colonies were selected for
inoculation into 96 well plates, subcultured three times to cure
plasmid pBRGP::tse2NT–v and pooled for plasmid isolation
yielding pACTR::tsi2*–V–zif. Purified plasmids were digested by
ScaI and T7 exonuclease for removal of pBRGP::tse2 NT–v. After
purification, the mutated pACT::tsi2*–V–zif plasmids were co-
transformed with pBRGP::tsi2–v into KDZif1DZ competent cells
and transformants were plated onto LB plates containing 12.5 mg/
ml tetracycline, 150 mg/ml carbenicillin, 50 mg/ml kanamycin,
40 mg/ml X-gal and 500 mM tPEG. LacZ positive (blue) colonies
were subcultured and subjected to plasmid isolation and
subsequent sequencing analysis.
b-Galactosidase assays
E. coli KDZif1DZ cells were grown to an OD600 of 1.0,
permeabilized with 10% CHCl3, and b-galactosidase activity was
quantitatively assayed using a Galacto-Light Plus kit as previously
described [52]. Assays were performed with at least two individual
experiments in triplicate. Representative data sets are shown and
values consist of averages based on three independent measure-
ments from one experiment.
Preparation of proteins and western blotting
Cell associated and supernatant protein samples were prepared
as previously described [7]. Western blotting was performed as
described previously using a-VSV-G, a-Tse2 and a-RNA-
polymerase, with the modification that a-VSV-G antibody
probing was performed in 5% BSA in Tris-buffered saline
containing 0.05% v/v Tween 20 [14]. HisProbe-HRP Kit was
used for direct detection of recombinant His-tagged proteins
according to the manufacturer’s instructions (Thermo Scientific).
Bacterial growth analyses
For growth curves, E. coli BL21 pLysS cells harboring pET29b+
expressing Tse2 and Tsi2 derivatives were grown overnight in
liquid LB broth at 37uC and back-diluted into LB broth (1:1000)
supplemented with 50 mg/ml kanamycin and 12.5 mg/ml chlor-
amphenicol. Cultures were grown to an OD600 of 0.1–0.2 and
induced with 0.2 mM IPTG. OD600 measurements were deter-
mined for E. coli strains in LB broth using an automated BioScreen
C Microbiology plate reader with agitation at 37uC. Three
independent measurements were performed in triplicate for each
strain. A VSV-G epitope sequence was fused to tsi2 to allow for
analyzing Tsi2 expression. For growth on solid medium, E. coli
BL21 pLysS cells expressing Tse2 and Tsi2 derivatives were grown
on LB agar plates with or without IPTG induction.
Circular dichroism spectroscopy
CD spectra were recorded on a Jasco J810 Circular Dichroism
Spectrometer using a 1 mm path-length quartz cuvette (Starna).
Tsi2 proteins were measured in triplicate at 195–260 nm in 16
PBS buffer, pH 7.5 at 25uC. A total of three scans were recorded
and averaged for each spectrum.
In vitro labeling with biotin-maleimide
Purified proteins were exchanged into a 16 PBS buffer
containing 50 mM NaCl, pH 7.5. Biotin-maleimide was solubilized
in Dimethyl sulfoxide (DMSO) and added to the protein samples at
a final concentration of 10 mM. Protein samples (10 mM) were
incubated with biotin-maleimide at room temperature and
reactions were quenched at indicated time points by the addition
of a final concentration of 0.1 mMTris, pH 8.0. Westernblots were
used to detect biotin-maleimide labeled Tsi2 with NeutrAvidin and
to detect His-tagged Tsi2 with HisProbe-HRP Kit.
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Purified Tsi2 was loaded onto a Superdex-200 10/300GL
HR10/30 column (GE Healthcare) equilibrated with a buffer
containing 50 mM Tris pH 7, 500 mM NaCl, and 5% glycerol.
Protein standards included ribonuclease A (13700 Da), carbonic
anhydrase (29000 Da), ovalbumin (43000 Da), conalbumin
(75000 Da), and aldolase (158000 Da).
Protein half-life determination
P. aeruginosa Dtse2Dtsi2 strains harboring pPSV35::tse2NT–V,
pPSV35::tse2–V tsi2–V or pPSV35::tse2NT–V tsi2–V were grown at
37uC with aeration in LB broth containing 30 mg/ml gentamycin.
Overnight cultures were back-diluted 1:500 into LB containing
30 mg/ml gentamycin and 0.5 mM IPTG. After P. aeruginosa cells
were grown at 37uC for 5 hrs., protein synthesis was inhibited with
the addition of 250 mg/ml tetracycline. Samples were taken at
indicated time points and analyzed by Western blot.
Supporting Information
Figure S1 Epitope tags and export via the H1-T6SS do
not account for the Tsi2 and Tse2 stability observed in
Figures 2B and 3C, respectively. Analysis of Tse2NT and V–
Tsi2 stability in P. aeruginosa DHSI-I Dtse2 Dtsi2 following the
inhibition of protein synthesis by the addition of tetracycline (Tet).
Top blot – the stability of untagged Tse2NT is similar to that
observed for the C-terminally VSV–G fused protein (Fig. 3C).
Bottom blot – N-terminally VSV–G fused Tsi2 (V–Tsi2) displays
similar stability to the C-terminally-tagged protein (Fig. 2B). These
experiments were conducted in an HSI-I deletion strain in order to
rule out Tse2 secretion as a factor contributing to its depletion
from cells.
(TIF)
Figure S2 Non-toxic Tse2 alleles express to similar
levels as the wild-type. Western blot analysis of the indicated
tse2–V alleles expressed in P. aeruginosa Dtse2Dtsi2 grown on LB
agar plates containing 30 mg/ml gentamycin and 0.5 mg/ml
IPTG. RNA polymerase (RNAP) was included as a loading
control.
(TIF)
Figure S3 Analytical gel filtration elution profile of the
Tsi2 dimer. Purified Tsi2–H6 was loaded onto a Superdex-200
10/300GL HR10/30 column (GE Health Care). Standard curves
were calculated using linear regression analysis.
(TIF)
Figure S4 Tsi2 surface amino acid alanine substitutions
do not affect its function. Growth of E. coli BL21 pLysS cells
harboring pET29b+ co-expressing tse2 with the indicated tsi2–V
alleles. Growth was measured in LB broth containing kanamycin
using the automated BioScreen C Microbiology plate reader with
agitation at 37uC. Bars represent growth normalized to tsi2 wild-
type at six hours post-inoculation. Error bars represent standard
deviation of three independent measurements.
(TIF)
Figure S5 Substitution of Tsi2 acidic patch residues
with lysine does not significantly alter structure. Far-UV





Figure S6 Tsi2 surface acidic residue lysine substitu-
tion mutants that do not impact homodimerization or
interaction with Tse2. B2H analysis of Tsi2 acidic residue
substitutions on homotypic (Tsi2) and heterotypic (Tse2) interac-
tions. Genes fused in-frame to RNAP–v and Zif are indicated.
(TIF)
Figure S7 Nonconservative substitutions of Cys14 and
polar dimer interface residues do not impact Tsi2 dimer
formation. B2H analysis of Tsi2 dimer interface amino acid
substitutions on Tsi2 dimerization. Genes fused in-frame to
RNAP–v and Zif are indicated.
(TIF)
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